文献速递创伤与烧伤消化、代谢与肾脏急症

阿司匹林与低分子肝素在骨科创伤患者中风险分层的血栓预防效果:PREVENT CLOT 试验的二次分析

Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: A secondary analysis of the PREVENT CLOT trial.
PubMed 文献 · J Trauma Acute Care Surg · 2023-12-08
一句话结论在骨科创伤患者中,即使静脉血栓栓塞高风险者,阿司匹林与低分子肝素预防血栓栓塞结局相似;若考虑用药满意度,阿司匹林更优。

PREVENT CLOT 试验的二次分析纳入 12,211 例成人骨折患者,按 Caprini 评分分为 VTE 风险四分位,用 win ratio 法比较阿司匹林与低分子肝素的疗效。高风险四分位(n=3052)中,阿司匹林与低分子肝素的静脉血栓栓塞事件无统计学差异(win ratio 0.94,95%CI 0.82-1.08,p=0.42),低、低中、中高风险四分位结果一致。若将用药满意度纳入复合终点,阿司匹林获得有利结局的可能性高 68%(win ratio 1.68,95%CI 1.60-1.77,p<0.001)。

要点

  • 在高 VTE 风险骨科创伤患者中,阿司匹林与低分子肝素的静脉血栓栓塞事件无统计学差异(win ratio 0.94,95%CI 0.82-1.08,p=0.42)。
  • 低风险(win ratio 1.15,95%CI 0.90-1.47,p=0.27)、低中风险(win ratio 1.05,95%CI 0.85-1.29,p=0.68)、中高风险(win ratio 0.94,95%CI 0.80-1.11,p=0.48)四分位结果与高风险一致。
  • 若将用药满意度纳入复合终点,阿司匹林获得有利结局的可能性高 68%(win ratio 1.68,95%CI 1.60-1.77,p<0.001)。
  • 高风险四分位中 80% 为股骨、骨盆或髋臼骨折,胸部损伤(47%)和头部损伤(37%)常见。

适用人群与场景

  • PREVENT CLOT 试验纳入的 12,211 例成人骨折患者;本二次分析按 Caprini 评分分为 VTE 风险四分位。
  • 高风险四分位(n=3052)中 80% 为股骨、骨盆或髋臼骨折,胸部损伤 47%,头部损伤 37%。
  • 低风险四分位(n=3053)中 67% 为胫骨骨折,5% 有胸部损伤,不足 1% 有头部或脊柱损伤。

诊断标准与关键阈值

  • 使用 Caprini 评分将 VTE 风险分为四分位:低风险(<1%)至高风险(>10%)。

研究设计与关键结果

  • 研究类型:PREVENT CLOT 试验的二次分析;样本量 12,211 例成人骨折患者;按 Caprini 评分分 VTE 风险四分位。
  • 高风险四分位(n=3052)中,阿司匹林与低分子肝素的血栓栓塞事件无统计学差异(win ratio 0.94;95%CI 0.82-1.08,p=0.42)。
  • 低风险四分位(win ratio 1.15;95%CI 0.90-1.47,p=0.27)、低中风险四分位(win ratio 1.05;95%CI 0.85-1.29,p=0.68)、中高风险四分位(win ratio 0.94;95%CI 0.80-1.11,p=0.48)结果与高风险一致。
  • 将用药满意度纳入复合终点后,阿司匹林获得有利结局的可能性高 68%(win ratio 1.68;95%CI 1.60-1.77;p<0.001)。

证据类型、等级与局限

  • 证据类型:PREVENT CLOT 试验的二次分析;证据等级:治疗/护理管理,Level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 即使 VTE 风险最高的骨科创伤患者,阿司匹林与低分子肝素预防血栓栓塞的结局相似。
  • 若考虑用药满意度,作者认为阿司匹林更优。

指南或共识出处

  • PREVENT CLOT 试验

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The PREVENT CLOT trial concluded that thromboprophylaxis with aspirin was noninferior to low-molecular-weight heparin (LMWH) in preventing death after orthopedic trauma. However, it was unclear if these results applied to patients at highest risk of thrombosis. Therefore, we assessed if the effect of aspirin versus LMWH differed based on patients' baseline risk of venous thromboembolism (VTE).

METHODS: The PREVENT CLOT trial enrolled 12,211 adult patients with fractures. This secondary analysis stratified the study population into VTE risk quartiles: low (<1%) to high (>10%) using the Caprini score. We assessed stratum-specific treatment effects using the win ratio method, in which each patient assigned to aspirin was paired with each assigned to LMWH. In each pair, we compared outcomes hierarchically, starting with death, then pulmonary embolism, deep vein thrombosis, and bleeding. The secondary outcome added patients' medication satisfaction as a fifth composite component.

RESULTS: In the high-risk quartile (n = 3052), 80% had femur fracture, pelvic, or acetabular fractures. Thoracic (47%) and head (37%) injuries were also common. In the low risk quartile (n = 3053), most patients had a tibia fracture (67%), 5% had a thoracic injury, and less than 1% had head or spinal injuries. Among high risk patients, thromboembolic events did not differ statistically between aspirin and LMWH (win ratio, 0.94; 95% confidence interval [CI], 0.82-1.08, p = 0.42). This result was consistent in the low (win ratio, 1.15; 95% CI, 0.90-1.47, p = 0.27), low-medium (win ratio, 1.05; 95% CI, 0.85-1.29, p = 0.68), and medium-high risk quartiles (win ratio, 0.94; 95% CI, 0.80-1.11, p = 0.48). When medication satisfaction was considered, favorable outcomes were 68% more likely with aspirin (win ratio, 1.68; 95% CI, 1.60-1.77; p < 0.001).

CONCLUSION: Thromboembolic outcomes were similar with aspirin or LMWH, even among patients at highest risk of VTE. Aspirin was favored if medication satisfaction was also considered.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. O'Hara NN, O'Toole RV, Frey KP, et al. Risk-stratified thromboprophylaxis effects of aspirin versus low-molecular-weight heparin in orthopedic trauma patients: A secondary analysis of the PREVENT CLOT trial. J Trauma Acute Care Surg. 2023. PMID: 38079260. doi:10.1097/TA.0000000000004226

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。